RMD insider Peter C. Farrell files sale notice for 2,000 shares

RMD: Peter C. Farrell reports proposed sale of 2,000 common shares issuable upon exercise of a stock option granted 11/11/2014 (exercise type: Cash).

Rhea-AI Filing Summary

RMD: Peter C. Farrell reports proposed sale of 2,000 common shares issuable upon exercise of a stock option granted 11/11/2014 (exercise type: Cash). The filing also lists three completed sales of 2,000 common shares each on 12/03/2025, 01/07/2026, and 02/04/2026.

Insights

Securities Counsel

Filing documents a stock-option exercise and three 2,000-share sales by Peter C. Farrell.

The notice records a stock option granted 11/11/2014 covering 2,000 common shares with Cash exercise. It separately lists sales of 2,000 shares on 12/03/2025, 01/07/2026, and 02/04/2026.

These entries are routine Section 144 disclosures describing a controlling-person sale pathway. Transaction timing and cash-flow counterparties are as stated; further details appear in the transactional records and broker confirmations, not in this excerpt.

FAQ

What does RMD's Form 144 filed for Peter C. Farrell report?

The Form 144 reports a proposed sale tied to a stock option granted on 11/11/2014 for 2,000 common shares with Cash exercise. It also lists three sales of 2,000 shares on 12/03/2025, 01/07/2026, and 02/04/2026.

How many shares did Peter C. Farrell sell recently according to the filing?

The filing shows three separate sales of 2,000 common shares each, occurring on 12/03/2025, 01/07/2026, and 02/04/2026, totaling 6,000 shares across those dates as listed in the excerpt.

What type of security is tied to the proposed sale in the RMD Form 144?

The proposed sale is tied to a Stock Option granted on 11/11/2014 covering 2,000 common shares. The exercise method shown in the excerpt is listed as Cash for that option.

Does the Form 144 excerpt state how proceeds will be used by the issuer RMD?

The excerpt does not state any use of proceeds by the issuer. It documents the reporting person (Peter C. Farrell), the security type, option grant date, exercise method, and specific sale dates and share counts only.

Where can investors find more transaction details beyond this Form 144 excerpt for RMD?

More detailed transaction information is typically available in broker confirmations, related Form 4/Form 5 filings, or company disclosure records. This excerpt provides share counts and dates but not broker counterparty or gross proceeds details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 06:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001186102
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ResMed INC
SEC File Number	001-15317
Address of Issuer	9001 Spectrum Center Blvd SAN DIEGO CALIFORNIA 92123
Phone	858-746-2400
Name of Person for Whose Account the Securities are To Be Sold	Peter C Farrell
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 2049 Century Park East, Ste 1200 Los Angeles CA 90067	2000	520360	44448959	03/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/11/2014	Stock Option	Peter C Farrell			2000	11/11/2014	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	12/03/2025	2000	502860
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	01/07/2026	2000	497580
Peter C Farrell 9001 Spectrum Center Blvd San Deigo CA 92123	Common	02/04/2026	2000	502540

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	PETER C FARRELL
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)